Attend the FierceBiotech Drug Development Forum
The leading executive-level forum for biotech strategy & networking | Oct 28-29 | Boston
Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.
The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.
Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.
The Gates Foundation brought on one of Apple’s healthcare project leaders to help lead its global digital health efforts, according to CNBC.
Biopharma and CRO veteran Beatrice Setnik, Ph.D., has become the new chief scientific officer at Canadian clinical research firm Altasciences.
Parexel has been on a recruiting spree of late, delving into FDA to beef up its regulatory offerings. Now, it’s turned to fellow biopharma services provider…
Nearly three years after it first teamed up with Takeda, PRA Health Sciences has bought out its joint venture with the Japanese pharma.
U.K.-based Eagle Genomics has expanded across the pond, taking a spot at the JLABS incubator located at the New York Genome Center.
Clinerion is offering up its blinded electronic health records to help train clinical research master’s students at Dresden International University.
The FDA and France's Dassault Systèmes are testing the latter's simulated heart model as a source of digital evidence for new device approvals.
